Market trends

Quarterly Results

Quarter-over-quarter and year-over-year numbers for unlisted companies, filed as results come in. Figures are each company’s own reported numbers — this page just lines them up. Every card links to the original filing.

Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)964948701+37.6%+1.7%
EBITDA (₹ Cr)712705466+53.0%+1.1%
EBITDA margin73.9%74.4%66.5%+7.5pt-0.5pt
PAT (₹ Cr)265297210+29.9%-10.6%
EPS (₹)148166118+25.4%-10.8%
Q2 FY27Q2 FY26YoY
Volume (Mn MMBtu)4216.15+160.1%
PAT (₹ Cr)23.49.59+144.0%
  • H1 FY27 volume was 70 Mn MMBtu vs 40.9 Mn MMBtu in H1 FY26 (+71.1%); H1 FY27 PAT was ₹39.7 Cr vs ₹23.72 Cr (+67.4%).
Q2 FY27Q2 FY26YoY
AUM (₹ Cr)6,4765,236+23.7%
Loan disbursement (₹ Cr)701544+28.9%
Revenue (₹ Cr)230191+20.7%
PAT (₹ Cr)3634+5.9%
ROA2.2%2.5%-0.3pt
ROE8.8%9.2%-0.4pt
Gross NPA1.5%1.6%-0.1pt
Net NPA0.9%0.9%0.0pt
Zero revenue reported
  • Reported ₹0 Cr revenue this quarter, pending regulatory approval and order execution.
  • Management guidance: ₹300–350 Cr FY27 topline, 30–35% EBITDA margin.
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)4,0674,5603,677+10.6%-10.8%
EBITDA (₹ Cr)3,0793,5461,484+107.5%-13.2%
EBITDA margin75.7%77.8%40.4%——
PAT (₹ Cr)2,5783,1202,098+22.9%-17.4%
EPS (₹)10.4112.618.48+22.8%-17.4%
Furlenco
Furlenco
H1 FY27
H1 FY27H1 FY26YoY
Subscriber base (000s)201148+35.8%
Revenue (₹ Cr)229170+34.7%
EBITDA (₹ Cr)8952.66+69.0%
EBITDA margin38.8%30.8%+8.0pt
T
Thyrocare
Q2 FY27
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)271240217+24.9%+12.9%
EBITDA (₹ Cr)897771+25.4%+15.6%
EBITDA margin33.0%32.0%33.0%——
PAT (₹ Cr)155148-68.8%-70.6%
EPS (₹)1.003.283.02-66.9%-69.5%
  • Thyrocare is API Holdings' subsidiary — API Holdings is the entity merging with PharmEasy (see the reverse-listing pipeline).
  • PAT's drop is an exceptional, one-off loss on the sale of a subsidiary, not an operating decline.
Q2 FY27Q1 FY27QoQ
Revenue (₹ Cr)115.64102.57+12.7%
Order book (₹ Cr)400288+38.9%
AI CyberOps revenue (₹ Cr)7513+476.9%
Team strength177152+16.4%
  • Management raised its FY27 billing target to ₹600 Cr from its earlier guidance of ₹300 Cr.
  • Expects meaningful EBITDA profitability to begin in FY28, with a mature IP-led business potentially targeting margins above 40%.
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)2,1532,1602,137+0.8%-0.3%
EBITDA (₹ Cr)1,058919757+39.8%+15.1%
PAT (₹ Cr)1498.4-112—+1673.8%
EPS (₹)11.540.65-8.71—+1675.4%
Gross NPA3.48%3.77%5.41%-1.9pt-0.3pt
Net NPA1.46%1.63%2.41%-0.9pt-0.2pt
  • PAT and EPS YoY are omitted — the year-ago quarter was a loss, so a % change isn't meaningful.
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)280.35258.02222.43+26.1%+8.7%
EBITDA (₹ Cr)199170163+22.1%+17.1%
PAT (₹ Cr)50.0236.6245.49+10.0%+36.6%
EPS (₹)2.752.012.52+9.1%+36.8%
Gross NPA2.71%2.69%2.48%+0.2pt+0.0pt
Net NPA1.82%1.81%1.66%+0.2pt+0.0pt
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)111.45107.4583.43+33.6%+3.7%
EBITDA (₹ Cr)60.1762.2048.34+24.5%-3.3%
PAT (₹ Cr)10.6913.757.04+51.9%-22.3%
EPS (₹)7.289.385.70+27.7%-22.4%
Gross NPA3.80%3.75%4.52%-0.7pt+0.1pt
Net NPA2.30%2.30%2.94%-0.6pt0.0pt
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)759736700+8.4%+3.1%
EBITDA (₹ Cr)457427412+10.9%+7.0%
PAT (₹ Cr)12010491+31.9%+15.4%
EPS (₹)8.957.756.82+31.2%+15.5%
Gross NPA4.71%4.95%4.77%-0.1pt-0.2pt
Net NPA3.20%3.21%3.27%-0.1pt-0.0pt
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)500.8478.59381+31.4%+4.6%
EBITDA (₹ Cr)296298155+91.0%-0.7%
PAT (₹ Cr)9810519+415.8%-6.7%
EPS (₹)6.416.881.28+400.8%-6.8%
Gross NPA0.89%0.88%2.00%-1.1pt+0.0pt
Net NPA0.20%0.13%0.52%-0.3pt+0.1pt
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)17.0720.3014.08+21.2%-15.9%
EBITDA (₹ Cr)-41.42-16.87-2.64——
EBITDA margin-242.6%-83.1%-18.8%——
PAT (₹ Cr)-52.26-24.71-4.09——
EPS (₹)-0.05-0.020.00——
  • MSEI is loss-making across all three quarters shown — EBITDA, PAT and EPS are negative throughout, so YoY/QoQ % changes aren't shown; they're not meaningful across widening losses.
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)54.9650.6131.21+76.1%+8.6%
EBITDA (₹ Cr)-9.20-5.80-14.37——
EBITDA margin-16.7%-11.5%-46.0%——
PAT (₹ Cr)-13.32-8.30-14.26——
EPS (₹)-1.45-0.92-2.71——
  • NCDEX remains loss-making across all three quarters shown — EBITDA, EBITDA margin, PAT and EPS are negative throughout, so YoY/QoQ % changes aren't shown.
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)91.3388.1991.95-0.7%+3.6%
EBITDA (₹ Cr)56.6049.9552.77+7.3%+13.3%
PAT (₹ Cr)4.882.426.25-21.9%+101.7%
EPS (₹)0.180.090.28-35.7%+100.0%
Gross NPA5.01%4.58%2.21%+2.8pt+0.4pt
Net NPA3.37%3.03%1.19%+2.2pt+0.3pt
Q2 FY27Q1 FY27Q2 FY26YoYQoQ
Revenue (₹ Cr)107.87179.91472.82-77.2%-40.0%
EBITDA (₹ Cr)36.9430.7935.35+4.5%+20.0%
EBITDA margin34.2%17.1%7.5%+26.8pt+17.1pt
PAT (₹ Cr)24.5820.2424.32+1.1%+21.4%
EPS (₹)28.8923.7928.58+1.1%+21.4%
  • Revenue fell sharply both year-over-year and quarter-over-quarter — the source filing gives no reason for the swing.